Lifecome Biochemistry Co.,Ltd. (SHE:002868)
China · Delayed Price · Currency is CNY 22.52
+0.36 (1.62%)
Aug 4, 2026, 3:04 PM CST
Lifecome Biochemistry Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | -73.38 | -139.26 | -444.86 | -221.82 | -121.94 | -26.04 |
Depreciation & Amortization | 69.62 | 97.85 | 100.24 | 71.06 | 64.17 | 33.94 |
Other Amortization | 1.51 | 2.88 | 1.57 | 0.07 | 0.19 | 0.03 |
Loss (Gain) From Sale of Assets | -0.02 | -0.27 | -0.04 | 0.04 | -0 | -0.01 |
Asset Writedown & Restructuring Costs | 2.59 | 3.04 | 171.99 | 24.86 | 6.25 | 0.22 |
Loss (Gain) From Sale of Investments | 1.43 | -4.55 | -9.25 | -11.43 | 10.12 | 20.56 |
Provision & Write-off of Bad Debts | 1.13 | -1.55 | 0.38 | 1.27 | 1.35 | 0.72 |
Other Operating Activities | 54.27 | 73.7 | 115.62 | 96.17 | 54.62 | 10.75 |
Change in Accounts Receivable | -16.72 | 22.59 | 47.21 | -51.58 | -3.78 | -17.23 |
Change in Inventory | -6.37 | -25.82 | 53.82 | -97.39 | -73.51 | -15.42 |
Change in Accounts Payable | -90.88 | -54.16 | 56.32 | 15.66 | 61.29 | 34.49 |
Change in Other Net Operating Assets | 2.07 | 1.54 | 30 | 4.61 | 3.79 | -0.86 |
Operating Cash Flow | -55.29 | -25.08 | 141.41 | -186.76 | -8.83 | 35.17 |
Operating Cash Flow Growth | - | - | - | - | - | -61.23% |
Capital Expenditures | -123.34 | -129.8 | -125.06 | -464.54 | -137.32 | -357.17 |
Sale of Property, Plant & Equipment | 30.32 | 3.8 | 0.49 | 4.93 | 0.02 | 4.24 |
Cash Acquisitions | - | - | - | -90.89 | - | - |
Divestitures | -3.63 | -3.63 | 27.28 | 294.94 | - | - |
Other Investing Activities | 1.13 | 1.13 | 7.46 | 1.31 | 0.44 | -2.09 |
Investing Cash Flow | -102.28 | -135.26 | -89.82 | -254.25 | -136.86 | -355.01 |
Long-Term Debt Issued | - | 1,148 | 807.58 | 910.8 | 364.79 | 292.89 |
Long-Term Debt Repaid | - | -907.25 | -838.33 | -454.83 | -281.03 | -42.5 |
Net Debt Issued (Repaid) | 245.5 | 240.32 | -30.76 | 455.97 | 83.75 | 250.39 |
Issuance of Common Stock | 3.37 | 3.37 | - | 35.7 | - | - |
Repurchase of Common Stock | -5.72 | -5.72 | - | - | - | - |
Common Dividends Paid | -42.69 | -42.52 | -48.83 | -24.22 | -12.99 | -26.53 |
Financing Cash Flow | 200.46 | 195.44 | -79.58 | 467.45 | 70.76 | 223.87 |
Foreign Exchange Rate Adjustments | -1.47 | -1 | -2.71 | -0.02 | 3.19 | -0.8 |
Net Cash Flow | 41.42 | 34.1 | -30.71 | 26.43 | -71.73 | -96.77 |
Free Cash Flow | -178.63 | -154.88 | 16.35 | -651.3 | -146.15 | -322 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -37.97% | -29.98% | 2.52% | -128.46% | -44.31% | -88.61% |
Free Cash Flow Per Share | -1.16 | -1.00 | 0.10 | -4.23 | -0.95 | -2.10 |
Levered Free Cash Flow | -429.99 | -415.6 | 21.82 | -231.91 | -464.01 | -258.76 |
Unlevered Free Cash Flow | -407.75 | -381.97 | 60.61 | -208.72 | -453.87 | -257 |
Cash Income Tax Paid | - | -4.14 | -33.58 | -28.32 | -46.96 | -31.32 |
Change in Working Capital | -112.44 | -56.9 | 205.76 | -146.97 | -23.59 | -5 |